Serial #98095927
LIVE

Serial Number

98095927

Owner

Crossbow Therapeutics, Inc.

Attorney

Michael R. Graif

First Use Date

Jul 10, 2025

Filing Date

Jul 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98095927 Trademark

Serial Number: 98095927 • Registration: 8223546

Serial #98095927 is a trademark filed by Crossbow Therapeutics, Inc. on July 21, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Crossbow Therapeutics, Inc. (25 trademarks)

1030 Massachusetts Avenue, Suite 210
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

July 21, 2023

Registration Date

April 21, 2026

First Use Anywhere

July 10, 2025

First Use in Commerce

July 10, 2025

Published for Opposition

May 7, 2024

Goods & Services

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders, ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of viral infections; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations, namely, antivirals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 30, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 30, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 28, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 28, 2026 AITU
USE AMENDMENT FILED
Sep 28, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 28, 2025 EISU
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 1, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 1, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 1, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
May 3, 2025 EX2G
SOU EXTENSION 2 FILED
May 2, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
May 2, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 23, 2024 EX1G
SOU EXTENSION 1 FILED
Jul 23, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 23, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 1, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 1, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 1, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 1, 2024 CNEA
ASSIGNED TO EXAMINER
Mar 26, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 22, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2023 NWOS
NEW APPLICATION ENTERED
Jul 25, 2023 NWAP